Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,298 | -19,791 | -10,008 | -17,748 | -17,424 |
| Depreciation Amortization | N/A | 14 | 4 | 4 | 4 |
| Income taxes - deferred | -1,088 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -936 | N/A | N/A |
| Other Working Capital | -404 | 6,539 | -866 | 822 | -1,984 |
| Other Operating Activity | 8,222 | 686 | -4,626 | -4,582 | 557 |
| Operating Cash Flow | $-10,568 | $-12,552 | $-16,432 | $-21,504 | $-18,847 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | 382 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $382 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,099 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 1,000 | N/A | N/A | N/A |
| Common Stock Issued | 12,124 | 11,843 | 7,020 | 25,288 | 14,293 |
| Other Financing Activity | -1,052 | -1,855 | 0 | 0 | 0 |
| Financing Cash Flow | $13,171 | $10,988 | $7,020 | $25,288 | $14,293 |
| Exchange Rate Effect | 1 | -4 | 7 | 105 | -141 |
| Beginning Cash Position | 2,659 | 3,845 | 13,250 | 9,361 | 14,056 |
| End Cash Position | 5,263 | 2,659 | 3,845 | 13,250 | 9,361 |
| Net Cash Flow | $2,604 | $-1,186 | $-9,405 | $3,889 | $-4,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,568 | -12,552 | -16,432 | -21,504 | -18,847 |
| Free Cash Flow | -10,568 | -12,552 | -16,432 | -21,504 | -18,847 |